These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19195932)

  • 21. Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.
    Hegedüs L; Smith TJ; Douglas RS; Nielsen CH
    Clin Endocrinol (Oxf); 2011 Jan; 74(1):1-8. PubMed ID: 20455896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saccadic eye movement velocity measured with the infrared reflection and search coil eye-tracking systems in patients with thyroid-associated ophthalmopathy.
    Träisk F; Bolzani R; Tallstedt L; Schworm HD; Ygge J
    Strabismus; 2007; 15(4):173-80. PubMed ID: 18058353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series.
    Savino G; Balia L; Colucci D; Battendieri R; Gari M; Corsello SM; Pontecorvi A; Dickmann A
    Minerva Endocrinol; 2013 Jun; 38(2):173-9. PubMed ID: 23732371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered ganglioside expression modulates the pathogenic mechanism of thyroid-associated ophthalmopathy by increase in hyaluronic acid.
    Kook KH; Choi YH; Kim YR; Park SJ; Jou I; Kim SJ; Lee SY
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):264-73. PubMed ID: 20811057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal anti-TNFalpha antibody (infliximab) in the treatment of patient with thyroid associated ophthalmopathy.
    Komorowski J; Jankiewicz-Wika J; Siejka A; Lawnicka H; Kłysik A; Goś R; Majos A; Stefańczyk L; Stepień H
    Klin Oczna; 2007; 109(10-12):457-60. PubMed ID: 18488396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pay attention to the study on the role of orbital fatty tissue in thyroid associated ophthalmopathy].
    Luo QL
    Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1057-9. PubMed ID: 17415959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of glucocorticoid receptor alpha and beta mRNA in orbital tissues in thyroid associated ophthalmopathy].
    Luo QL; He WM; Xia QJ; Cao GQ; Yan NH; Wang L; Zhang FQ
    Zhonghua Yan Ke Za Zhi; 2007 Jan; 43(1):40-3. PubMed ID: 17442162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy.
    Fang S; Huang Y; Wang N; Zhang S; Zhong S; Li Y; Sun J; Liu X; Wang Y; Gu P; Li B; Zhou H; Fan X
    J Clin Endocrinol Metab; 2019 May; 104(5):1697-1711. PubMed ID: 30517642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
    Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.
    Vannucchi G; Campi I; Bonomi M; Covelli D; Dazzi D; Currò N; Simonetta S; Bonara P; Persani L; Guastella C; Wall J; Beck-Peccoz P; Salvi M
    Clin Exp Immunol; 2010 Sep; 161(3):436-43. PubMed ID: 20529087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical investigation of tarsorrhaphy suture for treatment thyroid-associated ophthalmopathy].
    Luo QL; Tang L; He WM
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):777-80. PubMed ID: 16191341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid ophthalmopathy.
    Levy J; Sobel R; Marcus M; Lifshitz T
    Minerva Endocrinol; 2005 Dec; 30(4):247-65. PubMed ID: 16319812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ultrastructure analysis and cytokines expression of orbital fibroblasts in the patients with thyroid-associated ophthalmopathy].
    Luo QL; Zhang XJ; Zeng JH
    Zhonghua Yan Ke Za Zhi; 2003 Dec; 39(12):746-9. PubMed ID: 14769228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.
    Salvi M; Vannucchi G; Currò N; Campi I; Covelli D; Dazzi D; Simonetta S; Guastella C; Pignataro L; Avignone S; Beck-Peccoz P
    J Clin Endocrinol Metab; 2015 Feb; 100(2):422-31. PubMed ID: 25494967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-wall orbital decompression superiority to 2-wall orbital decompression in thyroid-associated ophthalmopathy.
    Cansiz H; Yilmaz S; Karaman E; Oğreden S; Acioğlu E; Sekercioğlu N; Pazarli H
    J Oral Maxillofac Surg; 2006 May; 64(5):763-9. PubMed ID: 16631482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The pathological changes of the orbital tissue in thyroid associated ophthalmopathy].
    Hei Y; Kang L; Li YY; Xiao LH
    Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):423-6. PubMed ID: 18953897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy.
    Chen MH; Chen MH; Liao SL; Chang TC; Chuang LM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):332-7. PubMed ID: 18284633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of CCR1 in the orbital fibroblasts with thyroid associated ophthalmopathy].
    Liu CL; Zhang XJ; Guo B; Yang JF; Luo QL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):630-2. PubMed ID: 22007486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of Graves' ophthalmopathy].
    Schalin-Jäntti C
    Duodecim; 2010; 126(20):2431-7. PubMed ID: 21125757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and immunological changes in patients with active moderate-to-severe Graves' orbitopathy treated with very low-dose rituximab.
    Karasek D; Cibickova L; Karhanova M; Kalitova J; Schovanek J; Frysak Z
    Endokrynol Pol; 2017; 68(5):498-504. PubMed ID: 28660988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.